gongze
NEWS
Set development, production, sales as a whole
-
10
2024-01
The company focuses on the discovery and development of pharmaceutical intermediates and raw material drugs -
14
2023-12
The company has successfully developed Erlotinib, Sunitinib, Kaunivartan hydrochloride, direnavir and other raw materials. -
20
2023-05
Amphetamine is a central nervous system stimulant and belongs to the amphetamine class of drugs. -
20
2023-04
4-chloropyrropyrimidine is an important pharmaceutical intermediate that is used, for example, as an intermediate for the treatment of tofacitinib in adult patients with.. -
17
2023-04
Conivaptan hydrochloride is a non-peptide dual inhibitor of the V1a and V2 receptors of arginine vasopressin (AVP).. -
10
2023-04
Sunitinib is a small molecule multi-target tyrosine kinase inhibitor and the first in a new class of drugs that can selectively target multiple receptor tyrosine kinases.